Product References
Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.
The EMBO journal
Hoffmann K,Berger H,Kulbe H,Thillainadarasan S,Mollenkopf HJ,Zemojtel T,Taube E,Darb-Esfahani S,Mangler M,Sehouli J,Chekerov R,Braicu EI,Meyer TF,Kessler M
MA1-10195 was used in Immunohistochemistry to illustrate that a low-Wnt enviorment coupled with active BMP signaling are required for generation and sustenance of HGSOC organoids.
Mon Mar 16 00:00:00 UTC 2020
Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease.
PloS one
Grzelak CA,Sigglekow ND,Tirnitz-Parker JE,Hamson EJ,Warren A,Maneck B,Chen J,Patkunanathan B,Boland J,Cheng R,Shackel NA,Seth D,Bowen DG,Martelotto LG,Watkins DN,McCaughan GW
MA110195 was used in immunohistochemistry to analyze the importance of canonical Hedgehog signaling within the primary cilia+ liver progenitor cell population in humans
Wed Aug 09 00:00:00 UTC 2017
Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells.
BMC cancer
Kershaw S,Cummings J,Morris K,Tugwood J,Dive C
MA1-10195 was used in western blot to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients
Sun May 10 00:00:00 UTC 2015
New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use.
International journal of cancer
Becker TM,Caixeiro NJ,Lim SH,Tognela A,Kienzle N,Scott KF,Spring KJ,de Souza P
MA1-10195 was used in immunocytochemistry to review the current state-of-the-art in circulating tumor cell profiling
Sun Jun 01 00:00:00 UTC 2014
Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition.
Cancer research
Nasarre P,Gemmill RM,Potiron VA,Roche J,Lu X,Barón AE,Korch C,Garrett-Mayer E,Lagana A,Howe PH,Drabkin HA
MA1-10195 was used in western blot to study TGF-beta1-driven lung cancer cell epithelial-to-mesenchymal transition and the role played by neuropilin-2
Sun Dec 01 00:00:00 UTC 2013
Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary.
Journal of cancer research and clinical oncology
Bauerschlag D,Bräutigam K,Moll R,Sehouli J,Mustea A,Salehin D,Krajewska M,Reed JC,Maass N,Hampton GM,Meinhold-Heerlein I
MA1-10195 was used in immunohistochemistry to identify genes differentially expressed in ovaraian serous adenocarcinoma as compared to healthy ovarian tissue
Fri Feb 01 00:00:00 UTC 2013
Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.
PloS one
Mosoyan G,Nagi C,Marukian S,Teixeira A,Simonian A,Resnick-Silverman L,DiFeo A,Johnston D,Reynolds SR,Roses DF,Mosoian A
MA1-10195 was used in flow cytometry to study the different molecular phenotype and tumorigenicity of 5 breast cancer cell lines derived from a single patient
Fri Jul 26 00:00:00 UTC 2013
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.
British journal of cancer
Khoja L,Backen A,Sloane R,Menasce L,Ryder D,Krebs M,Board R,Clack G,Hughes A,Blackhall F,Valle JW,Dive C
MA1-10195 was used in immunocytochemistry and immunohistochemistry - paraffin section to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer
Tue Jan 31 00:00:00 UTC 2012
Transient but not stable ZEB1 knockdown dramatically inhibits growth of malignant pleural mesothelioma cells.
Annals of surgical oncology
Horio M,Sato M,Takeyama Y,Elshazley M,Yamashita R,Hase T,Yoshida K,Usami N,Yokoi K,Sekido Y,Kondo M,Toyokuni S,Gazdar AF,Minna JD,Hasegawa Y
MA1-10195 was used in western blot to study the role of ZEB1 in mediating the growth of malignant pleural mesothelioma cells
Sun Jul 01 00:00:00 UTC 2012
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.
Nature genetics
Ligtenberg MJ,Kuiper RP,Chan TL,Goossens M,Hebeda KM,Voorendt M,Lee TY,Bodmer D,Hoenselaar E,Hendriks-Cornelissen SJ,Tsui WY,Kong CK,Brunner HG,van Kessel AG,Yuen ST,van Krieken JH,Leung SY,Hoogerbrugge N
MA1-10195 was used in immunohistochemistry to investigate Lynch syndrome with MSH2-deficient tumors
Thu Jan 01 00:00:00 UTC 2009
Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.
Oncogene
Meinhold-Heerlein I,Bauerschlag D,Hilpert F,Dimitrov P,Sapinoso LM,Orlowska-Volk M,Bauknecht T,Park TW,Jonat W,Jacobsen A,Sehouli J,Luttges J,Krajewski M,Krajewski S,Reed JC,Arnold N,Hampton GM
MA1-10195 was used in immunohistochemistry to distinguish low malignant potential serous ovarian carcinomas from invasive counterparts
Thu Feb 03 00:00:00 UTC 2005
Gene expression patterns in ovarian carcinomas.
Molecular biology of the cell
Schaner ME,Ross DT,Ciaravino G,Sorlie T,Troyanskaya O,Diehn M,Wang YC,Duran GE,Sikic TL,Caldeira S,Skomedal H,Tu IP,Hernandez-Boussard T,Johnson SW,O'Dwyer PJ,Fero MJ,Kristensen GB,Borresen-Dale AL,Hastie T,Tibshirani R,van de Rijn M,Teng NN,Longacre TA,Botstein D,Brown PO,Sikic BI
MA1-10195 was used in immunohistochemistry to study gene expression patterns in ovarian carcinomas using DNA microarrays
Sat Nov 01 00:00:00 UTC 2003